Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the β-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4

Diabetes

Volumn 51, Issue 5, 2002, Pages 1443-1452

  Tourrel, Cécile ^a,b   Bailbe, Danielle ^a   Lacorne, Matthieu ^a   Meile, Marie Jo ^a   Kergoat, Micheline ^b   Portha, Bernard ^a  

^a CNRS   (France)

^b Merck Lipha   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; INSULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HORMONE ACTION; HYPERGLYCEMIA; INJECTION; INSULIN BLOOD LEVEL; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 0036312680     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.5.1443     Document Type: Article

References (33)

1. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited
2. Natural history of beta-cell dysfunction in NIDDM
3. Glucagon-like peptides
4. The glucagon-like peptides
5. Minireview: The glucagon-like peptides
6. Isolation and characterization of Ex-4, an exendin-3 analogue, from Heloderma suspectum venom: Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas
7. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells
8. Initiation of increased pancreatic islet growth in young normoglycemic mice (Umea +/?)
9. Ex-4 stimulates both β-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats
10. Glucagon-like peptide-1 and Ex-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells
11. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas
12. GK rat as a model of non-obese, non-insulin dependent diabetes: Selective breeding over 35 generations
13. Lack of deterioration of insulin action with aging in the GK rat: A contrasted adaptation as compared with non-diabetic rats
14. Beta-cell mass depletion precedes the onset of hyperglycemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus
15. Cellular basis of pancreatic β-cells in non-insulin dependent diabetes
16. Impaired development of pancreatic β-cell mass is a primary event during the progression to diabetes in the GK rats
17. The life story of the pancreatic β-cell
18. Islet growth and development in adult
19. Dynamics of β-cell mass in the growing rat pancreas: Estimation with a simple mathematical model
20. Insulin administration enhances growth of the β-cell mass in streptozotocin-treated newborn rats
21. Glucagon-like peptide-1 and Ex-4 stimulate β-cell neogenesis in streptozotocin-treated newborn rats, resulting in persistently glucose homeostasis at adult age
22. β-cell dysfunction induced by chronic hyperglycemia: Current ideas on mechanisms of impaired glucose-induced insulin secretion
23. Accelerated loss of islet β-cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus
24. Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by alpha-glucosidase inhibitor
25. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1
26. Cloning and functional expression of the human islet GLP-1-receptor: Demonstration that Ex4 is an agonist and exendin (9-39) is an antagonist of the receptor
27. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
28. Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling
29. Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice
30. Effects of glucagon-like peptide-1 on glucose turnover in rats
31. Glucose toxicity
32. Relation between hyperglycemia and impairment of insulin secretion and action: Information from the n-STZ models
33. Improved glucose tolerance restores insulin-stimulated Akt-kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kaki rats